Citations 3
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians
Dave, Kuldip D. , Yersak, Jill, Krauss, Ramona , Heiman‐Patterson, Terry , Lomen‐Hoerth, Catherine , Selig, Wendy , Paul, Ilisa Halpern, Schaeffer, Melody , Garcia-Trujillo, Brittany, Waldo, Daniel R., Thakur, Neil , Babu, Suma , Oskarsson, Björn
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | December 10, 2024 | Volume: 26 | Issue: 3-4 | Pages: 215-224
Clinician Education Initiatives for General Neurologists on ALS: Why It Is Needed and ThinkALS, a Possible Solution (P5-11.008)
Yersak, Jill, Krauss, Ramona , Heiman‐Patterson, Terry , Lomen‐Hoerth, Catherine , Waldo, D. B., Selig, Wendy , Paul, Ilisa Halpern, Dave, Kuldip D. , Babu, Suma , Oskarsson, Björn , Thakur, Neil
Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Lee, Eudocia Q. , Selig, Wendy , Meehan, Clair, Bacha, Jeffrey , Barone, Amy , Chang, Susan M. , Galanis, Evanthia , Hassan, Islam , Kalidas, Chitkala , Lassman, Andrew B. , Sahebjam, Solmaz , Welch, Mary , Yung, W.K. Alfred, Zadeh, Gelareh , Arons, David, Wen, Patrick Y. , Galanis, Evanthia , Khasraw, Mustafa , Zadeh, Gelareh , Bloomquist, Erik W. , Chang, Susan Marina , Groot, John de , Khasraw, Mustafa , Kvedar, Joseph C. , Puduvalli, Vinay K. , Schwamm, Lee H. , Tamir, Sharon, Wen, Patrick Yung
Neuro-Oncology | March 31, 2021 | Volume: 23 | Issue: 8 | Pages: 1252-1260
Abstract On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.